bioAffinity Technologies receives US patent allowance for lung cancer test

Go back to bioAffinity Technologies receives US patent allowance for lung cancer test
(NASDAQ: BIAF) Delayed: 0.86 +0.02 (2.38%)
Previous Close $0.84    52 Week High
Open $0.82    52 Week Low
Day High $0.87    P/E N/A 
Day Low $0.82    EPS
Volume 287,097       

(NASDAQ: BIAFW) Delayed: 0.14 --0 (-0%)
Previous Close $0.14    52 Week High
Open $0.14    52 Week Low
Day High $0.14    P/E N/A 
Day Low $0.14    EPS
Volume 2,429,247